Federal Register / Vol. 80, No. 63 / Thursday, April 2, 2015 / Notices 17757 

Commission, Office of the Secretary, 

600 Pennsylvania Avenue NW., Suite 

CC–5610 (Annex J), or deliver your 

comment to the following address: 

Federal Trade Commission, Office of the 

Secretary, Constitution Center, 400 7th 

Street SW., 5th Floor, Suite 5610 

(Annex J), Washington, DC 20024. If 

possible, submit your paper comment to 

the Commission by courier or overnight 

service. 

The FTC Act and other laws that the 

Commission administers permit the 

collection of public comments to 

consider and use in this proceeding as 

appropriate. The Commission will 

consider all timely and responsive 

public comments that it receives on or 

before June 1, 2015. For information on 

the Commission’s privacy policy, 

including routine uses permitted by the 

Privacy Act, see http://www.ftc.gov/ftc/ 

privacy.htm. 

David C. Shonka, 

Principal Deputy General Counsel. 

[FR Doc. 2015–07552 Filed 4–1–15; 8:45 am] 

BILLING CODE 6750–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Solicitation of Written Comments on 

Draft National Pain Strategy 

SUMMARY: The National Institute of 

Neurological Disorders and Stroke 

(NINDS) Office of Pain Policy is 

soliciting public comment on the draft 

National Pain Strategy. 

DATES: Comments on the draft National 

Pain Strategy must be received no later 

than 5 p.m. EST on May 20, 2015. 

ADDRESSES: The draft National Pain 

Strategy is available at: http:// 

iprcc.nih.gov/docs/ 

DraftHHSNationalPainStrategy.pdf. 

Written comments sent electronically 

are preferred and may be addressed to 

NPSPublicComments@NIH.gov. Written 

responses should be addressed to Linda 

Porter, Ph.D., NINDS/NIH, 31 Center 

Drive, Room 8A31, Bethesda, MD 

20892. 

FOR FURTHER INFORMATION CONTACT: 

Contact Linda Porter, Ph.D., NINDS/ 

NIH, 31 Center Drive, Room 8A31, 

Bethesda, MD 20892, 

porterl@ninds.nih.gov. 

SUPPLEMENTARY INFORMATION: The draft 

National Pain Strategy reflects the work 

of many offices across the Department of 

Health and Human Services, 

Department of Defense, and Department 

of Veterans Affairs. The draft National 

Pain Strategy also reflects input from 

scientific and clinical experts and pain 

patient advocates. It includes objectives 

and plans related to key areas of pain 

and pain care, including professional 

education and training, public 

education and communication, service 

delivery and reimbursement, prevention 

and care, disparities, and population 

research. 

I. Background 

A core recommendation of the 2011 

IOM Report: Relieving Pain in America 

is: ‘‘The Secretary of the Department of 

Health and Human Services should 

develop a comprehensive, population 

health-level strategy for pain 

prevention, treatment, management, 

education, reimbursement, and research 

that includes specific goals, actions, 

time frames, and resources.’’ The IOM 

report highlighted specific objectives for 

the strategy: 

• Describe how efforts across 

government agencies, including publicprivate partnerships, can be established, 

coordinated, and integrated to 

encourage population-focused research, 

education, communication, and 

community-wide approaches that can 

help reduce pain and its consequences 

and remediate disparities in the 

experience of pain among subgroups of 

Americans. 

• Include an agenda for developing 

physiological, clinical, behavioral, 

psychological, outcomes, and health 

services research and appropriate links 

across these domains. 

• Improve pain assessment and 

management programs within the 

service delivery and financing programs 

of the federal government. 

• Proceed in cooperation with the 

Interagency Pain Research Coordinating 

Committee and the National Institutes of 

Health’s Pain Consortium and reach out 

to private-sector participants as 

appropriate. 

• Involve the appropriate agencies 

and entities. 

• Include ongoing efforts to enhance 

public awareness about the nature of 

chronic pain and the role of self-care in 

its management. 

The Department of Health and Human 

Services charged the Interagency Pain 

Research Coordinating Committee 

(IPRCC) with creating a comprehensive 

population health-level strategy to begin 

addressing these objectives. 

II. Information Request 

The NINDS Office of Pain Policy, on 

behalf of DHHS, requests input on the 

draft National Pain Strategy. 

III. Potential Responders 

HHS invites input from a broad range 

of individuals and organizations that 

have interests in advancing the 

fundamental understanding of pain and 

improving pain-related treatment 

strategies. Some examples of these 

organizations include, but are not 

limited to the following: 

• Caregivers or health system providers 

(e.g., physicians, physician assistants, 

nurses, pharmacists) 

• Researchers 

• Foundations 

• Health care, professional, and 

educational organizations/societies 

• Insurers and business groups 

• Medicaid- and Medicare-related 

organizations 

• Patients and their advocates 

• Pharmaceutical Industry 

• Public health organizations 

• State and local public health agencies 

When responding, please self-identify 

with any of the above or other categories 

(include all that apply) and your name. 

Anonymous submissions will not be 

considered. Written materials submitted 

for consideration should not exceed 5 

pages, not including appendices and 

supplemental documents. Responders 

may submit other forms of electronic 

materials to demonstrate or exhibit 

concepts of their written responses. We 

request that comments be identified by 

section, subsection, and page number of 

the draft so they may be addressed 

accordingly. All comments received 

before the close of the comment period 

are available for viewing by the public, 

including any personally identifiable or 

confidential business information that is 

included in a comment. 

Dated: March 25, 2015. 

Walter J. Koroshetz, 

Acting Director, National Institute of 

Neurological Disorders and Stroke, National 

Institutes of Health. 

[FR Doc. 2015–07626 Filed 4–1–15; 8:45 am] 

BILLING CODE CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2015–N–0001] 

Biomedical Engineering Society and 

FDA Frontiers in Medical Devices: 

Innovations in Modeling and 

Simulation 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice of Public Conference 

The Food and Drug Administration 

(FDA) in co-sponsorship with the 


tkelley on DSK3SPTVN1PROD with NOTICES
17758 Federal Register / Vol. 80, No. 63 / Thursday, April 2, 2015 / Notices 

Biomedical Engineering Society (BMES) 

is announcing a public conference 

entitled ‘‘Frontiers in Medical Devices: 

Innovations in Modeling and 

Simulation’’. The purpose of this 

conference is to provide a forum to 

discuss strategies to effectively utilize 

computational modeling and simulation 

in the development and evaluation of 

medical devices. 

Date and Time: The conference will 

be held on May 18 through 20, 2015, 

from 8 a.m. to 6 p.m. 

Location: The public conference will 

be held at the Marriott Inn and 

Conference Center, University of 

Maryland, 3501 University Blvd. East, 

Hyattsville, MD 20783. 

Contact Person: Donna R. Lochner, 

Center for Devices and Radiological 

Health, Food and Drug Administration, 

10903 New Hampshire Ave., Bldg. 62, 

Rm. 3220, Silver Spring, MD 20993, 

301–796–6309, Donna.Lochner@

fda.hhs.gov. 

Registration: To register for the public 

conference please visit FDA’s Medical 

Devices News, Events, Workshops, and 

Conferences calendar at http://

www.bmes.org/meddevicesconference. 

There is a registration fee to attend the 

public conference to cover the expenses, 

and attendees must register in advance. 

The fees vary depending upon 

membership status in BMES, and 

include BMES members ($450), nonBMES members (includes 1 year BMES 

membership) ($600), and Government 

rate (BMES memberships and meals are 

not included) ($250). Students will be 

offered a discounted fee of $300 (BMES 

member) or $350 (non-BMES member) 

(includes 1 year BMES membership). A 

full listing of the registration fees can be 

found on the Web site listed. Although 

the facilities are spacious, registration 

will be on a first-come, first-served 

basis. 

If you need special accommodations 

due to a disability, please contact Betse 

Lyons at Betse@bmes.org or 301–459– 

1999, 8201 Corporate Drive, Suite 1125, 

Landover, MD 20785–2224, FAX: 301– 

459–2444, no later than May 4, 2015. 

To register for the public conference, 

please visit BMES Frontiers in Medical 

Devices registration page at http://

bmes.org/meddevicesregistration. Those 

without Internet access should contact 

Betse Lyons at 301–459–1999 to register. 

SUPPLEMENTARY INFORMATION: 

I. Background 

The Center for Devices and 

Radiological Health (CDRH) believes 

that computer modeling and simulation 

(M&S) has the potential to substantially 

augment traditional models used to 

evaluate medical devices; i.e., animal, 

bench, and human models, and to 

accelerate and streamline the total 

product life cycle of a medical device. 

The use of computer models to simulate 

multiple use conditions and to visualize 

and display complex processes and data 

can revolutionize the way medical 

outcomes and medical devices are 

understood. Non-proprietary computer 

models could benchmark device 

performance, yet lack of access to 

biomedical data to construct the models 

and rigorous methods to validate the 

models limit their credibility and use. 

To foster good science for M&S in the 

medical device community, CDRH 

needs to leverage the expertise in 

industry and academia to advance M&S 

for regulatory uses. 

II. Topics for Discussion at the Public 

Workshop 

A large number of issues will be 

discussed at the conference with the 

overall theme being the application of 

modeling and simulation for medical 

devices at different stages in the total 

product life cycle. Topics include, but 

are not limited to the following: 

• Model foundations for device 

design ideation; 

• concept development and design 

optimization; 

• modeling for robust design; 

• design verification and validation; 

• patient specific design; 

• integration of modeling with 

clinical studies; 

• modeling and device 

commercialization. 

This public workshop may also form 

the basis for future discussions related 

to computer modeling and simulation 

that could benefit U.S. public health. 

Dated: March 27, 2015. 

Leslie Kux, 

Associate Commissioner for Policy. 

[FR Doc. 2015–07551 Filed 4–1–15; 8:45 am] 

BILLING CODE CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute Of Mental Health; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; 

Mentoring Programs for HIV/AIDS 

Researchers 2. 

Date: March 30, 2015. 

Time: 11:00 a.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852, (Telephone 

Conference Call). 

Contact Person: Aileen Schulte, Ph.D., 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, NIH, Neuroscience Center, 

6001 Executive Blvd., Room 6140, MSC 9608, 

Bethesda, MD 20892–9608, 301–443–1225, 

aschulte@mail.nih.gov 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.242, Mental Health Research 

Grants, National Institutes of Health, HHS) 

Dated: March 27, 2015. 

Carolyn A. Baum, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–07507 Filed 4–1–15; 8:45 am] 

BILLING CODE CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2011–N–0481] 

Agency Information Collection 

Activities; Proposed Collection; 

Comment Request; New Animal Drugs 

for Investigational Uses 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing an 

opportunity for public comment on the 

proposed collection of certain 

information by the Agency. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), Federal Agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension of an existing collection of 

information, and to allow 60 days for 

public comment in response to the 

notice. This notice solicits comments on 


tkelley on DSK3SPTVN1PROD with NOTICES